New 2020 Website Coming Soon!
Boston BioPharm Inc, 550 Reserve St Ste 190-250, Southlake Texas 76092
To meet the immediate need for testing and help save lives, Boston BioPharm partnered with GeneMatrix, under an exclusive license and technology transfer for the NeoPlexTM line of diagnostic products, in North & South America and Europe.
Our partner GeneMatrix was founded in December 2000 and is a global biotechnology leader in the field of molecular diagnostics. They have developed and own numerous patented molecular diagnostic technologies such as C-TAG, Omniplex, EnCleap, TriO & REMP which have been applied to Hepatitis B and C, cervical cancer, sexually transmitted infections, gastrointestinal infections and respiratory infections including influenza.
Together, GeneMatrix and Boston BioPharm pioneered an approved KFDA, FDA, CE-IVD NeoPlexTM Covid-19 Detection Kit with clinical detection results shown to be 100% accurate.
About NeoPlex/Patent-Protected Technology:
NeoPlexTM Covid-19 Detection Kit (100% Accuracy/FDA IFU), nucleic acid extraction/analysis (molecular test). Regulatory Status: FDA EUA Approved (EUA200803 authorization number) KFDA, and EU-IVD
Compatible with all Real-Real Time PCR (96 & 384 well plate) and automatic extraction Instruments:- 100% Accurate Testing Results unlike most tests (see FDA IFU Document)